PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Advanced Preventive Medicine for Infectious Disease, Tohoku University Graduate School of Medicine.\', \'Department of Respiratory Medicine, Tohoku University Graduate School of Medicine.\', \'Virus Research Center, Clinical Research Division, Sendai Medical Center.\', \'Department of Kampo and Integrative Medicine, Tohoku University Graduate School of Medicine.\', \'Laboratory of Health and Sports Science, Division of Biomedical Engineering for Health and Welfare, Tohoku University Graduate School of Biomedical Engineering.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1620/tjem.251.27
?:doi
?:hasPublicationType
?:journal
  • The Tohoku journal of experimental medicine
is ?:pmid of
?:pmid
?:pmid
  • 32448818
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Protease Inhibitors: Candidate Drugs to Inhibit Severe Acute Respiratory Syndrome Coronavirus 2 Replication.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all